These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8627247

  • 1. Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia.
    Shepherd PS, Rowe AJ, Cridland JC, Coletart T, Wilson P, Luxton JC.
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():593-602. PubMed ID: 8627247
    [Abstract] [Full Text] [Related]

  • 2. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals.
    Luxton JC, Rowe AJ, Cridland JC, Coletart T, Wilson P, Shepherd PS.
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1585-93. PubMed ID: 8758003
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus type 16-specific T cell responses and their association with recurrence of cervical disease following treatment.
    Luxton JC, Nath R, Derias N, Herbert A, Shepherd PS.
    J Gen Virol; 2003 May; 84(Pt 5):1063-1070. PubMed ID: 12692269
    [Abstract] [Full Text] [Related]

  • 4. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
    de Gruijl TD, Bontkes HJ, Walboomers JM, Coursaget P, Stukart MJ, Dupuy C, Kueter E, Verheijen RH, Helmerhorst TJ, Duggan-Keen MF, Stern PL, Meijer CJ, Scheper RJ.
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
    Kadish AS, Ho GY, Burk RD, Wang Y, Romney SL, Ledwidge R, Angeletti RH.
    J Natl Cancer Inst; 1997 Sep 03; 89(17):1285-93. PubMed ID: 9293919
    [Abstract] [Full Text] [Related]

  • 8. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.
    Luxton JC, Rose RC, Coletart T, Wilson P, Shepherd PS.
    J Gen Virol; 1997 Apr 03; 78 ( Pt 4)():917-23. PubMed ID: 9129666
    [Abstract] [Full Text] [Related]

  • 9. IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan.
    Matsumoto K, Yoshikawa H, Yasugi T, Nakagawa S, Kawana K, Takeoka A, Yaegashi N, Iwasaka T, Kanazawa K, Taketani Y, Kanda T.
    J Med Virol; 2003 Mar 03; 69(3):441-6. PubMed ID: 12526056
    [Abstract] [Full Text] [Related]

  • 10. Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.
    Yang W, Song Y, Lu YL, Sun JZ, Wang HW.
    Immunology; 2013 Aug 03; 139(4):513-22. PubMed ID: 23521696
    [Abstract] [Full Text] [Related]

  • 11. A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.
    Muderspach L, Wilczynski S, Roman L, Bade L, Felix J, Small LA, Kast WM, Fascio G, Marty V, Weber J.
    Clin Cancer Res; 2000 Sep 03; 6(9):3406-16. PubMed ID: 10999722
    [Abstract] [Full Text] [Related]

  • 12. T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia.
    Nakagawa M, Stites DP, Farhat S, Judd A, Moscicki AB, Canchola AJ, Hilton JF, Palefsky JM.
    Clin Diagn Lab Immunol; 1996 Mar 03; 3(2):205-10. PubMed ID: 8991637
    [Abstract] [Full Text] [Related]

  • 13. Comparison of cervical and blood T-cell responses to human papillomavirus-16 in women with human papillomavirus-associated cervical intraepithelial neoplasia.
    Passmore JA, Milner M, Denny L, Sampson C, Marais DJ, Allan B, Gumbi PP, Hitzeroth II, Rybicki EP, Williamson AL.
    Immunology; 2006 Dec 03; 119(4):507-14. PubMed ID: 17026720
    [Abstract] [Full Text] [Related]

  • 14. Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study.
    Sarkar AK, Tortolero-Luna G, Follen M, Sastry KJ.
    Gynecol Oncol; 2005 Dec 03; 99(3 Suppl 1):S251-61. PubMed ID: 16188303
    [Abstract] [Full Text] [Related]

  • 15. T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer.
    Chan PK, Liu SJ, Cheung TH, Yeo W, Ngai SM, Cheung JL, Chong P, Man S.
    Clin Vaccine Immunol; 2010 Sep 03; 17(9):1315-21. PubMed ID: 20668141
    [Abstract] [Full Text] [Related]

  • 16. IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia.
    Matsumoto K, Yasugi T, Oki A, Fujii T, Nagata C, Sekiya S, Hoshiai H, Taketani Y, Kanda T, Kawana T, Yoshikawa H.
    Cancer Lett; 2006 Jan 18; 231(2):309-13. PubMed ID: 16399232
    [Abstract] [Full Text] [Related]

  • 17. Analysis of CD4(+) T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types.
    Williams OM, Hart KW, Wang EC, Gelder CM.
    J Virol; 2002 Aug 18; 76(15):7418-29. PubMed ID: 12097554
    [Abstract] [Full Text] [Related]

  • 18. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia.
    Gill DK, Bible JM, Biswas C, Kell B, Best JM, Punchard NA, Cason J.
    J Gen Virol; 1998 Aug 18; 79 ( Pt 8)():1971-6. PubMed ID: 9714245
    [Abstract] [Full Text] [Related]

  • 19. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology.
    Tsukui T, Hildesheim A, Schiffman MH, Lucci J, Contois D, Lawler P, Rush BB, Lorincz AT, Corrigan A, Burk RD, Qu W, Marshall MA, Mann D, Carrington M, Clerici M, Shearer GM, Carbone DP, Scott DR, Houghten RA, Berzofsky JA.
    Cancer Res; 1996 Sep 01; 56(17):3967-74. PubMed ID: 8752165
    [Abstract] [Full Text] [Related]

  • 20. T-cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer.
    Chan PK, Liu SJ, Cheung JL, Cheung TH, Yeo W, Chong P, Man S.
    J Med Virol; 2011 Jun 01; 83(6):1023-30. PubMed ID: 21503915
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.